Glioblastoma is a dangerous brain malignancy known for its fast growth and unresponsiveness to typical treatments. Studies are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential target for GBM treatment. LCA168 is a pro